JP4080541B2
(ja)
|
1996-10-18 |
2008-04-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特にc型肝炎ウイルスns3プロテアーゼの阻害因子
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
HUP0500456A3
(en)
|
2000-11-20 |
2012-05-02 |
Bristol Myers Squibb Co |
Hepatitis c tripeptide inhibitors, pharmaceutical compositions comprising thereof and their use
|
US6867185B2
(en)
|
2001-12-20 |
2005-03-15 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus
|
ES2315568T3
(es)
|
2002-05-20 |
2009-04-01 |
Bristol-Myers Squibb Company |
Inhibidores del virus de la hepatitis c basados en cicloalquilo p1' sustituido.
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
ATE481106T1
(de)
|
2002-05-20 |
2010-10-15 |
Bristol Myers Squibb Co |
Heterocyclische sulfonamid-hepatitis-c-virus- hemmer
|
EP1506172B1
(en)
|
2002-05-20 |
2011-03-30 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
US20050075279A1
(en)
*
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
US20050159345A1
(en)
*
|
2002-10-29 |
2005-07-21 |
Boehringer Ingelheim International Gmbh |
Composition for the treatment of infection by Flaviviridae viruses
|
US7176208B2
(en)
*
|
2003-04-18 |
2007-02-13 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
|
PT1654261E
(pt)
|
2003-05-21 |
2008-01-18 |
Boehringer Ingelheim Int |
Compostos inibidores da hepatite c
|
WO2004111077A1
(en)
|
2003-06-18 |
2004-12-23 |
Tranzyme Pharma Inc. |
Macrocyclic antagonists of the motilin receptor
|
TW201127828A
(en)
|
2003-09-05 |
2011-08-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
DE602004031645D1
(de)
*
|
2003-09-22 |
2011-04-14 |
Boehringer Ingelheim Pharma |
Makrozyklische peptide mit wirkung gegen das hepatitis-c-virus
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
DK1680137T3
(da)
|
2003-10-14 |
2013-02-18 |
Hoffmann La Roche |
Makrocyklisk carboxylsyre- og acylsulfonamidforbindelse som inhibitor af HCV-replikation
|
US7132504B2
(en)
|
2003-11-12 |
2006-11-07 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2539575C
(en)
*
|
2003-11-20 |
2015-01-20 |
Boehringer Ingelheim International Gmbh |
Method of removing transition metals, especially from metathesis reaction products
|
US7309708B2
(en)
|
2003-11-20 |
2007-12-18 |
Birstol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7135462B2
(en)
|
2003-11-20 |
2006-11-14 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP2007513200A
(ja)
*
|
2003-12-08 |
2007-05-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
超臨界流体処理によるルテニウム副生物の除去
|
CA2549851C
(en)
*
|
2004-01-21 |
2012-09-11 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis c virus
|
AR048401A1
(es)
|
2004-01-30 |
2006-04-26 |
Medivir Ab |
Inhibidores de la serina-proteasa ns3 del vhc
|
US7582770B2
(en)
|
2004-02-20 |
2009-09-01 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
BRPI0509467A
(pt)
*
|
2004-03-30 |
2007-09-11 |
Intermune Inc |
compostos macrocìclicos como inibidores de replicação viral
|
WO2005118620A2
(en)
|
2004-05-27 |
2005-12-15 |
New York University |
Methods for preparing internally constraied peptides and peptidomimetics
|
AR050174A1
(es)
*
|
2004-07-16 |
2006-10-04 |
Gilead Sciences Inc |
Derivados de fosfonatos con actividad antiviral. composiciones farmaceuticas
|
EP1771454B1
(en)
|
2004-07-20 |
2011-06-15 |
Boehringer Ingelheim International GmbH |
Hepatitis c inhibitor peptide analogs
|
UY29016A1
(es)
|
2004-07-20 |
2006-02-24 |
Boehringer Ingelheim Int |
Analogos de dipeptidos inhibidores de la hepatitis c
|
JP2008513454A
(ja)
*
|
2004-09-17 |
2008-05-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
大環状hcvプロテアーゼインヒビターの調製方法
|
CA2578428A1
(en)
*
|
2004-09-17 |
2006-03-30 |
Boehringer Ingelheim International Gmbh |
Ring-closing metathesis process in supercritical fluid
|
CN102160891A
(zh)
*
|
2004-10-01 |
2011-08-24 |
威特克斯医药股份有限公司 |
Hcv ns3-ns4a蛋白酶抑制
|
CA2583152A1
(en)
*
|
2004-10-21 |
2006-04-27 |
Pfizer Inc. |
Inhibitors of hepatitis c virus protease, and compositions and treatments using the same
|
TW201424733A
(zh)
|
2004-10-29 |
2014-07-01 |
Vertex Pharma |
劑量型式
|
DE102005002336A1
(de)
*
|
2005-01-17 |
2006-07-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Durchführung von kontinuierlichen Olefin-Ringschluss-Metathesen in komprimiertem Kohlendioxid
|
US7323447B2
(en)
|
2005-02-08 |
2008-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7879797B2
(en)
|
2005-05-02 |
2011-02-01 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
US7592336B2
(en)
|
2005-05-10 |
2009-09-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7601686B2
(en)
|
2005-07-11 |
2009-10-13 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TWI387603B
(zh)
*
|
2005-07-20 |
2013-03-01 |
Merck Sharp & Dohme |
Hcv ns3蛋白酶抑制劑
|
JP5249028B2
(ja)
|
2005-07-25 |
2013-07-31 |
インターミューン・インコーポレーテッド |
C型肝炎ウイルス複製の新規大環状阻害剤
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
KR20080036598A
(ko)
*
|
2005-08-01 |
2008-04-28 |
머크 앤드 캄파니 인코포레이티드 |
Hcv ns3 프로테아제 억제제로서의 마크로사이클릭펩티드
|
EP1915378A4
(en)
|
2005-08-12 |
2009-07-22 |
Boehringer Ingelheim Int |
VIRUS POLYMERASE INHIBITORS
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
DE602006019323D1
(de)
|
2005-10-11 |
2011-02-10 |
Intermune Inc |
Verbindungen und verfahren zur inhibierung der replikation des hepatitis-c-virus
|
US7772183B2
(en)
|
2005-10-12 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7741281B2
(en)
|
2005-11-03 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
JP5436864B2
(ja)
|
2006-02-27 |
2014-03-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Vx−950を含む共結晶体およびそれを含む医薬組成物
|
EP1993994A2
(en)
|
2006-03-16 |
2008-11-26 |
Vertex Pharmceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
GB0609492D0
(en)
*
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
KR20090024834A
(ko)
*
|
2006-07-05 |
2009-03-09 |
인터뮨, 인크. |
C형 간염 바이러스 복제의 신규 억제제
|
WO2008008776A2
(en)
|
2006-07-11 |
2008-01-17 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
US7718612B2
(en)
*
|
2007-08-02 |
2010-05-18 |
Enanta Pharmaceuticals, Inc. |
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
|
RU2009109355A
(ru)
|
2006-08-17 |
2010-09-27 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Ингибиторы вырусной полимеразы
|
AU2007309546A1
(en)
|
2006-10-24 |
2008-05-02 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
HCV NS3 protease inhibitors
|
WO2008051514A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
US8138164B2
(en)
|
2006-10-24 |
2012-03-20 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
CN101568346B
(zh)
|
2006-10-27 |
2015-11-25 |
默沙东公司 |
Hcv ns3蛋白酶抑制剂
|
CA2667031C
(en)
|
2006-10-27 |
2013-01-22 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
US8343477B2
(en)
|
2006-11-01 |
2013-01-01 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8003604B2
(en)
|
2006-11-16 |
2011-08-23 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7888464B2
(en)
|
2006-11-16 |
2011-02-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7763584B2
(en)
|
2006-11-16 |
2010-07-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
AU2007335962B2
(en)
|
2006-12-20 |
2012-09-06 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Antiviral indoles
|
WO2008096001A1
(en)
*
|
2007-02-08 |
2008-08-14 |
Tibotec Pharmaceuticals Ltd. |
Hcv inhibiting macrocyclic phenylcarbamates
|
ES2379905T3
(es)
|
2007-02-27 |
2012-05-04 |
Vertex Pharmceuticals Incorporated |
Co-cristales y composiciones farmacéuticas que los comprenden
|
NZ579295A
(en)
|
2007-02-27 |
2012-03-30 |
Vertex Pharma |
Inhibitors of serine proteases
|
JP2010526834A
(ja)
*
|
2007-05-10 |
2010-08-05 |
インターミューン・インコーポレーテッド |
C型肝炎ウイルス複製の新規ペプチド阻害剤
|
AR067180A1
(es)
*
|
2007-06-29 |
2009-09-30 |
Gilead Sciences Inc |
Compuestos antivirales
|
EP2162431B1
(en)
|
2007-06-29 |
2017-06-07 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8513186B2
(en)
|
2007-06-29 |
2013-08-20 |
Gilead Sciences, Inc. |
Antiviral compounds
|
EP2178885A1
(en)
|
2007-07-17 |
2010-04-28 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Macrocyclic indole derivatives for the treatment of hepatitis c infections
|
WO2009010804A1
(en)
|
2007-07-19 |
2009-01-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Macrocyclic compounds as antiviral agents
|
US8242140B2
(en)
|
2007-08-03 |
2012-08-14 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
CL2008002549A1
(es)
|
2007-08-30 |
2010-09-03 |
Vertex Pharma |
Cocristal que comprende vx-950 y un formador de cocristal seleccionado de acido 3-metoxi-4hidroxibenzoico,acido 2,4-dihidroxibenzoico y acido 2,5-dihidroxibenzoico; metodo de preparacion; composicion farmaceutica que comprende el cocristal, util como agente antiviral en el tratamiento del hcv.
|
US8419332B2
(en)
*
|
2007-10-19 |
2013-04-16 |
Atlas Bolt & Screw Company Llc |
Non-dimpling fastener
|
WO2009076173A2
(en)
|
2007-12-05 |
2009-06-18 |
Enanta Pharmaceuticals, Inc. |
Fluorinated tripeptide hcv serine protease inhibitors
|
US8476257B2
(en)
|
2007-12-19 |
2013-07-02 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8202996B2
(en)
|
2007-12-21 |
2012-06-19 |
Bristol-Myers Squibb Company |
Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
|
EP2250174B1
(en)
|
2008-02-04 |
2013-08-28 |
IDENIX Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
SG175692A1
(en)
|
2008-04-15 |
2011-11-28 |
Intermune Inc |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
US8163921B2
(en)
|
2008-04-16 |
2012-04-24 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2720850A1
(en)
|
2008-04-28 |
2009-11-05 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
JP5529120B2
(ja)
|
2008-05-29 |
2014-06-25 |
ブリストル−マイヤーズ スクイブ カンパニー |
C型肝炎ウイルス阻害剤
|
US7964560B2
(en)
|
2008-05-29 |
2011-06-21 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
PL2310095T3
(pl)
|
2008-07-22 |
2013-03-29 |
Msd Italia Srl |
Makrocykliczne związki chinoksaliny jako inhibitory proteazy NS3 HCV
|
US8207341B2
(en)
|
2008-09-04 |
2012-06-26 |
Bristol-Myers Squibb Company |
Process or synthesizing substituted isoquinolines
|
UY32099A
(es)
|
2008-09-11 |
2010-04-30 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de serina proteasas de hepatitis c
|
US8044087B2
(en)
|
2008-09-29 |
2011-10-25 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8563505B2
(en)
|
2008-09-29 |
2013-10-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2743912A1
(en)
*
|
2008-11-20 |
2010-05-27 |
Achillion Pharmaceuticals, Inc. |
Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
|
US8283310B2
(en)
|
2008-12-15 |
2012-10-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2379579A1
(en)
*
|
2008-12-19 |
2011-10-26 |
Gilead Sciences, Inc. |
Hcv ns3 protease inhibitors
|
SG172848A1
(en)
|
2009-01-07 |
2011-08-29 |
Scynexis Inc |
Cyclosporine derivative for use in the treatment of hcv and hiv infection
|
JP2012517478A
(ja)
|
2009-02-12 |
2012-08-02 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ペグ化インターフェロン、リバビリンおよびテラプレビルを含む、hcv組合せ治療剤
|
AR075584A1
(es)
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
US8377962B2
(en)
|
2009-04-08 |
2013-02-19 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
EP2429568B1
(en)
|
2009-05-13 |
2016-08-17 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic compounds as hepatitis c virus inhibitors
|
US8232246B2
(en)
*
|
2009-06-30 |
2012-07-31 |
Abbott Laboratories |
Anti-viral compounds
|
WO2011014487A1
(en)
|
2009-07-30 |
2011-02-03 |
Merck Sharp & Dohme Corp. |
Hepatitis c virus ns3 protease inhibitors
|
AR077712A1
(es)
|
2009-08-05 |
2011-09-14 |
Idenix Pharmaceuticals Inc |
Inhibidores de serina proteasa macrociclica
|
MY159958A
(en)
|
2009-12-18 |
2017-02-15 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
KR20120139699A
(ko)
|
2010-01-29 |
2012-12-27 |
버텍스 파마슈티칼스 인코포레이티드 |
C형 간염 바이러스 감염의 치료 요법
|
WO2011156545A1
(en)
|
2010-06-09 |
2011-12-15 |
Vertex Pharmaceuticals Incorporated |
Viral dynamic model for hcv combination therapy
|
WO2012009503A1
(en)
|
2010-07-14 |
2012-01-19 |
Vertex Pharmaceuticals Incorporated |
Palatable pharmaceutical composition comprising vx-950
|
PE20140015A1
(es)
|
2010-09-21 |
2014-02-16 |
Enanta Pharm Inc |
Inhibidores de las proteasas de serina del vhc derivados de prolinas macrociclicas
|
AU2011352145A1
(en)
|
2010-12-30 |
2013-07-18 |
Abbvie Inc. |
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
|
MX2013007677A
(es)
|
2010-12-30 |
2013-07-30 |
Abbvie Inc |
Inhibidores macrociclicos de serina proteasa de hepatitis.
|
WO2012109398A1
(en)
|
2011-02-10 |
2012-08-16 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
|
WO2012109646A1
(en)
|
2011-02-11 |
2012-08-16 |
Vertex Pharmaceuticals Incorporated |
Treatment of hcv in hiv infection patients
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
US8957203B2
(en)
|
2011-05-05 |
2015-02-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
US8691757B2
(en)
|
2011-06-15 |
2014-04-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US20130195797A1
(en)
|
2012-01-31 |
2013-08-01 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
CN102617705B
(zh)
*
|
2012-02-16 |
2014-12-31 |
上海纬诺医药科技有限公司 |
抑制丙肝病毒复制的大环类化合物
|
CN104822682A
(zh)
|
2012-10-08 |
2015-08-05 |
艾伯维公司 |
用于制备hcv蛋白酶抑制剂的化合物
|
MX360452B
(es)
|
2012-10-19 |
2018-11-01 |
Bristol Myers Squibb Co |
Inhibidores del virus de la hepatitis c.
|
US9643999B2
(en)
|
2012-11-02 |
2017-05-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US9598433B2
(en)
|
2012-11-02 |
2017-03-21 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2014071007A1
(en)
|
2012-11-02 |
2014-05-08 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
WO2014070974A1
(en)
|
2012-11-05 |
2014-05-08 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
WO2014137869A1
(en)
|
2013-03-07 |
2014-09-12 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
EP3089757A1
(en)
|
2014-01-03 |
2016-11-09 |
AbbVie Inc. |
Solid antiviral dosage forms
|
EP3114122A1
(en)
|
2014-03-05 |
2017-01-11 |
Idenix Pharmaceuticals LLC |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
WO2015134561A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
CN110256536B
(zh)
*
|
2019-05-13 |
2022-09-13 |
中国人民解放军第二军医大学 |
一种抗丙型肝炎病毒感染合成肽及其应用
|
CN117105928B
(zh)
*
|
2023-08-22 |
2024-03-26 |
上海蓝木化工有限公司 |
一种蛋白酶抑制剂及其制备方法
|